End points for cardiovascular drug studies:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York
Raven Pr.
1984
|
Schriftenreihe: | Atherosclerosis reviews
12 |
Schlagworte: | |
Beschreibung: | XIII, 200 S. Ill. |
ISBN: | 0890049556 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV000276831 | ||
003 | DE-604 | ||
005 | 19891204 | ||
007 | t | ||
008 | 870612s1984 a||| |||| 10||| eng d | ||
020 | |a 0890049556 |9 0-89004-955-6 | ||
035 | |a (OCoLC)11114290 | ||
035 | |a (DE-599)BVBBV000276831 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-91 |a DE-578 | ||
050 | 0 | |a RC692 | |
082 | 0 | |a 616.1/061 |2 19 | |
082 | 0 | |a 616.1/36 |2 19 | |
084 | |a MED 410f |2 stub | ||
084 | |a MED 970f |2 stub | ||
245 | 1 | 0 | |a End points for cardiovascular drug studies |c ed. Ruth Johnsson Hegyeli |
264 | 1 | |a New York |b Raven Pr. |c 1984 | |
300 | |a XIII, 200 S. |b Ill. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Atherosclerosis reviews |v 12 | |
650 | 4 | |a Arteriosclerosis |v Congresses | |
650 | 4 | |a Arteriosclerosis |x diagnosis |v Congresses | |
650 | 4 | |a Atherosclerosis |v Congresses | |
650 | 4 | |a Atherosclerosis |x Chemotherapy |v Congresses | |
650 | 4 | |a Cardiovascular Agents |x pharmacology |v Congresses | |
650 | 4 | |a Cardiovascular Agents |x therapeutic use |v Congresses | |
650 | 4 | |a Cardiovascular Diseases |x drug therapy |v Congresses | |
650 | 4 | |a Cardiovascular agents |v Congresses | |
650 | 4 | |a Ultrasonography |v Congresses | |
650 | 0 | 7 | |a Evaluation |0 (DE-588)4071034-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kreislaufmittel |0 (DE-588)4163325-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1983 |z Rom |2 gnd-content | |
689 | 0 | 0 | |a Kreislaufmittel |0 (DE-588)4163325-8 |D s |
689 | 0 | 1 | |a Evaluation |0 (DE-588)4071034-8 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Hegyeli, Ruth J. |e Sonstige |4 oth | |
830 | 0 | |a Atherosclerosis reviews |v 12 |w (DE-604)BV002544390 |9 12 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-000167976 |
Datensatz im Suchindex
_version_ | 1804114741656813568 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV000276831 |
callnumber-first | R - Medicine |
callnumber-label | RC692 |
callnumber-raw | RC692 |
callnumber-search | RC692 |
callnumber-sort | RC 3692 |
callnumber-subject | RC - Internal Medicine |
classification_tum | MED 410f MED 970f |
ctrlnum | (OCoLC)11114290 (DE-599)BVBBV000276831 |
dewey-full | 616.1/061 616.1/36 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.1/061 616.1/36 |
dewey-search | 616.1/061 616.1/36 |
dewey-sort | 3616.1 261 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01806nam a2200517 cb4500</leader><controlfield tag="001">BV000276831</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19891204 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1984 a||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0890049556</subfield><subfield code="9">0-89004-955-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)11114290</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000276831</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC692</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/061</subfield><subfield code="2">19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/36</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 410f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">End points for cardiovascular drug studies</subfield><subfield code="c">ed. Ruth Johnsson Hegyeli</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 200 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Atherosclerosis reviews</subfield><subfield code="v">12</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arteriosclerosis</subfield><subfield code="x">diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Atherosclerosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Atherosclerosis</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ultrasonography</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1983</subfield><subfield code="z">Rom</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Evaluation</subfield><subfield code="0">(DE-588)4071034-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hegyeli, Ruth J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Atherosclerosis reviews</subfield><subfield code="v">12</subfield><subfield code="w">(DE-604)BV002544390</subfield><subfield code="9">12</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000167976</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1983 Rom gnd-content |
genre_facet | Konferenzschrift 1983 Rom |
id | DE-604.BV000276831 |
illustrated | Illustrated |
indexdate | 2024-07-09T15:11:32Z |
institution | BVB |
isbn | 0890049556 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000167976 |
oclc_num | 11114290 |
open_access_boolean | |
owner | DE-12 DE-91 DE-BY-TUM DE-578 |
owner_facet | DE-12 DE-91 DE-BY-TUM DE-578 |
physical | XIII, 200 S. Ill. |
publishDate | 1984 |
publishDateSearch | 1984 |
publishDateSort | 1984 |
publisher | Raven Pr. |
record_format | marc |
series | Atherosclerosis reviews |
series2 | Atherosclerosis reviews |
spelling | End points for cardiovascular drug studies ed. Ruth Johnsson Hegyeli New York Raven Pr. 1984 XIII, 200 S. Ill. txt rdacontent n rdamedia nc rdacarrier Atherosclerosis reviews 12 Arteriosclerosis Congresses Arteriosclerosis diagnosis Congresses Atherosclerosis Congresses Atherosclerosis Chemotherapy Congresses Cardiovascular Agents pharmacology Congresses Cardiovascular Agents therapeutic use Congresses Cardiovascular Diseases drug therapy Congresses Cardiovascular agents Congresses Ultrasonography Congresses Evaluation (DE-588)4071034-8 gnd rswk-swf Kreislaufmittel (DE-588)4163325-8 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1983 Rom gnd-content Kreislaufmittel (DE-588)4163325-8 s Evaluation (DE-588)4071034-8 s DE-604 Hegyeli, Ruth J. Sonstige oth Atherosclerosis reviews 12 (DE-604)BV002544390 12 |
spellingShingle | End points for cardiovascular drug studies Atherosclerosis reviews Arteriosclerosis Congresses Arteriosclerosis diagnosis Congresses Atherosclerosis Congresses Atherosclerosis Chemotherapy Congresses Cardiovascular Agents pharmacology Congresses Cardiovascular Agents therapeutic use Congresses Cardiovascular Diseases drug therapy Congresses Cardiovascular agents Congresses Ultrasonography Congresses Evaluation (DE-588)4071034-8 gnd Kreislaufmittel (DE-588)4163325-8 gnd |
subject_GND | (DE-588)4071034-8 (DE-588)4163325-8 (DE-588)1071861417 |
title | End points for cardiovascular drug studies |
title_auth | End points for cardiovascular drug studies |
title_exact_search | End points for cardiovascular drug studies |
title_full | End points for cardiovascular drug studies ed. Ruth Johnsson Hegyeli |
title_fullStr | End points for cardiovascular drug studies ed. Ruth Johnsson Hegyeli |
title_full_unstemmed | End points for cardiovascular drug studies ed. Ruth Johnsson Hegyeli |
title_short | End points for cardiovascular drug studies |
title_sort | end points for cardiovascular drug studies |
topic | Arteriosclerosis Congresses Arteriosclerosis diagnosis Congresses Atherosclerosis Congresses Atherosclerosis Chemotherapy Congresses Cardiovascular Agents pharmacology Congresses Cardiovascular Agents therapeutic use Congresses Cardiovascular Diseases drug therapy Congresses Cardiovascular agents Congresses Ultrasonography Congresses Evaluation (DE-588)4071034-8 gnd Kreislaufmittel (DE-588)4163325-8 gnd |
topic_facet | Arteriosclerosis Congresses Arteriosclerosis diagnosis Congresses Atherosclerosis Congresses Atherosclerosis Chemotherapy Congresses Cardiovascular Agents pharmacology Congresses Cardiovascular Agents therapeutic use Congresses Cardiovascular Diseases drug therapy Congresses Cardiovascular agents Congresses Ultrasonography Congresses Evaluation Kreislaufmittel Konferenzschrift 1983 Rom |
volume_link | (DE-604)BV002544390 |
work_keys_str_mv | AT hegyeliruthj endpointsforcardiovasculardrugstudies |